跳至主要内容
临床试验/NCT00372645
NCT00372645已完成不适用

Effects Of A Mixed Diet Intervention Versus Folic Acid Supplementation And Metafolin® Supplementation On Folate Status And Cardiovascular Disease Risk Factors In Healthy Adults

Quadram Institute Bioscience2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2005年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
180
试验地点
2
主要终点
Folate status

研究概览

简要总结

The aim of this study is to determine the best source of folate to raise the folate status of a general population over a 16 week intervention period.

详细描述

This study is designed to assess whether increasing the consumption of natural food folates from a mixed diet is as effective as supplemental folic acid or supplemental natural folate in raising folate status, reducing biomarkers of cardio vascular disease (CVD) risk, and improving vascular function. Randomised placebo-controlled parallel studies will be undertaken in groups of individuals in Norwich and Sheffield. There will be four treatment arms: a) 200 µg folate per day from folate-rich foods, b) 200 µg folate per day from supplemental folic acid, c) 200 µg folate per day from supplemental Metafolin® (6S 5-methyltetrahydrofolic acid) and d) a placebo group. Results from the two centres will be combined, thus ensuring a wide population is covered. Folate status, biomarkers of CVD risk and vascular function (pulse wave velocity) will be measured before and following the intervention period of 16 weeks, together with possible confounders (such as vitamins B2 & B12 status, and MTHFR genotype). 7-Day weighed intakes will be used to measure habitual B-vitamin intake during baseline and intervention, to determine changes in folate intake and assist compliance. Additionally, folate content of selected folate-rich foods will be determined for each volunteer. The results will aid the Food Standards Agency (FSA) in formulating public health policy related to improving folate status and reducing CVD risk.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women aged 18-65 years
  • Smokers and non-smokers

排除标准

  • Pregnant or has been pregnant within the last 12 months
  • Breastfeeding
  • Has donated or intends to donate blood within 16 weeks of the first or last study samples
  • Fails standard clinical screening of blood and urine for human studies at the Institute of Food Reseach
  • BMI above 18 or below 40
  • Receiving vascular disease or anti-hypertensive drugs
  • Those with diabetes
  • Regularly consuming dietary supplements containing B-vitamins and/or folic acid.
  • [As the capsules are prepared from gelatin, true vegetarians may not wish to participate]

研究组 & 干预措施

Diet

Experimental

200 µg folate per day from folate-rich foods

干预措施: Folate rich foods (Other)

Folic acid supplement

Experimental

200 µg folate per day from supplemental folic acid

干预措施: Folic acid (supplement) (Dietary Supplement)

Metfolin supplement

Experimental

200 µg folate per day from supplemental Metafolin®

干预措施: Metafolin (supplement) (Dietary Supplement)

Placebo

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Folate status

时间窗: Baseline and 16 weeks

Homocysteine status

时间窗: Baseline and 16 weeks

次要结局

  • Cardio vascular disease markers(Baseline and 16 weeks)
  • Inflammatory markers(Baseline and 16 weeks)
  • Pulse wave velocity(Baseline and 16 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验